Shock-and-kill Versus Block-and-lock: Targeting the Fluctuating and Heterogeneous HIV-1 Gene Expression

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2021 Mar 24

PMID 33758027

Citations 7

Authors

Yang-Hui Jimmy Yeh

Ya-Chi Ho

Affiliations

Soon will be listed here.

Citing Articles

Viral cis-regulatory elements as sensors of cellular states and environmental cues.

Rottenberg J, Taslim T, Soto-Ugaldi L, Martinez-Cuesta L, Martinez-Calejman C, Fuxman Bass J Trends Genet. 2024; 40(9):772-783.

PMID: 38821843 PMC: 11387143. DOI: 10.1016/j.tig.2024.05.004.

Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting "block and lock" treatment strategies.

Horvath R, Brumme Z, Sadowski I Antimicrob Agents Chemother. 2024; 68(3):e0107223.

PMID: 38319085 PMC: 10923280. DOI: 10.1128/aac.01072-23.

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman.

Di Girolamo L, Ferrara M, Trevisan G, Longo B, Allice T, Burdino E Virol J. 2023; 20(1):123.

PMID: 37312093 PMC: 10262927. DOI: 10.1186/s12985-023-02086-z.

Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal.

Moran J, Ranjan A, Hourani R, Kim J, Wender P, Zack J Virology. 2023; 581:8-14.

PMID: 36842270 PMC: 10103183. DOI: 10.1016/j.virol.2023.02.009.

Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption.

Lau C, Adan M, Earhart J, Seamon C, Nguyen T, Savramis A Front Med (Lausanne). 2022; 9:979756.

PMID: 36072945 PMC: 9441850. DOI: 10.3389/fmed.2022.979756.

References

Mousseau G, Clementz M, Bakeman W, Nagarsheth N, Cameron M, Shi J . An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. Cell Host Microbe. 2012; 12(1):97-108. PMC: 3403716. DOI: 10.1016/j.chom.2012.05.016. View

Lu Y, Bohn-Wippert K, Pazerunas P, Moy J, Singh H, Dar R . Screening for gene expression fluctuations reveals latency-promoting agents of HIV. Proc Natl Acad Sci U S A. 2021; 118(11). PMC: 7980449. DOI: 10.1073/pnas.2012191118. View

Rasmussen T, Sogaard O, Brinkmann C, Wightman F, Lewin S, Melchjorsen J . Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation. Hum Vaccin Immunother. 2013; 9(5):993-1001. PMC: 3899169. DOI: 10.4161/hv.23800. View

Weinberger L, Burnett J, Toettcher J, Arkin A, Schaffer D . Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell. 2005; 122(2):169-82. DOI: 10.1016/j.cell.2005.06.006. View

Wei D, Chiang V, Fyne E, Balakrishnan M, Barnes T, Graupe M . Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing. PLoS Pathog. 2014; 10(4):e1004071. PMC: 3983056. DOI: 10.1371/journal.ppat.1004071. View

Tsai A, Irrinki A, Kaur J, Cihlar T, Kukolj G, Sloan D . Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy. J Virol. 2017; 91(8). PMC: 5375698. DOI: 10.1128/JVI.02166-16. View

Hayashi T, Jean M, Huang H, Simpson S, Santoso N, Zhu J . Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription. Antiviral Res. 2017; 146:76-85. PMC: 5654649. DOI: 10.1016/j.antiviral.2017.08.013. View

Jones R, Mueller S, OConnor R, Rimpel K, Sloan D, Karel D . A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. PLoS Pathog. 2016; 12(4):e1005545. PMC: 4833318. DOI: 10.1371/journal.ppat.1005545. View

Bosque A, Nilson K, Macedo A, Spivak A, Archin N, Wagoner R . Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. Cell Rep. 2017; 18(5):1324-1334. PMC: 5461578. DOI: 10.1016/j.celrep.2017.01.022. View

10.

Nixon C, Mavigner M, Sampey G, Brooks A, Spagnuolo R, Irlbeck D . Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. 2020; 578(7793):160-165. PMC: 7111210. DOI: 10.1038/s41586-020-1951-3. View

11.

Matthews J, Wakasugi N, Virelizier J, Yodoi J, Hay R . Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 1992; 20(15):3821-30. PMC: 334054. DOI: 10.1093/nar/20.15.3821. View

12.

Archin N, Liberty A, Kashuba A, Choudhary S, Kuruc J, Crooks A . Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012; 487(7408):482-5. PMC: 3704185. DOI: 10.1038/nature11286. View

13.

Arkin A, Ross J, McAdams H . Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. Genetics. 1998; 149(4):1633-48. PMC: 1460268. DOI: 10.1093/genetics/149.4.1633. View

14.

Dar R, Hosmane N, Arkin M, Siliciano R, Weinberger L . Screening for noise in gene expression identifies drug synergies. Science. 2014; 344(6190):1392-6. PMC: 4122234. DOI: 10.1126/science.1250220. View

15.

Novis C, Archin N, Buzon M, Verdin E, Round J, Lichterfeld M . Reactivation of latent HIV-1 in central memory CD4⁺ T cells through TLR-1/2 stimulation. Retrovirology. 2013; 10:119. PMC: 3826617. DOI: 10.1186/1742-4690-10-119. View

16.

Yang H, Xing S, Shan L, OConnell K, Dinoso J, Shen A . Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest. 2009; 119(11):3473-86. PMC: 2769176. DOI: 10.1172/JCI39199. View

17.

Gavegnano C, Detorio M, Montero C, Bosque A, Planelles V, Schinazi R . Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro. Antimicrob Agents Chemother. 2014; 58(4):1977-86. PMC: 4023721. DOI: 10.1128/AAC.02496-13. View

18.

Yeh Y, Jenike K, Calvi R, Chiarella J, Hoh R, Deeks S . Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation. J Clin Invest. 2020; 130(9):4969-4984. PMC: 7456222. DOI: 10.1172/JCI137371. View

19.

Kalantari P, Narayan V, Natarajan S, Muralidhar K, Gandhi U, Vunta H . Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages. J Biol Chem. 2008; 283(48):33183-90. PMC: 2586244. DOI: 10.1074/jbc.M807403200. View

20.

Lacombe B, Morel M, Margottin-Goguet F, Ramirez B . Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells. J Virol. 2016; 90(23):10972-10980. PMC: 5110165. DOI: 10.1128/JVI.01722-16. View